SINGLE LINEAGE CYTOPENIAS, T-LGL

Clinical trials for SINGLE LINEAGE CYTOPENIAS, T-LGL explained in plain language.

Never miss a new study

Get alerted when new SINGLE LINEAGE CYTOPENIAS, T-LGL trials appear

Sign up with your email to follow new studies for SINGLE LINEAGE CYTOPENIAS, T-LGL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for tough blood disorders: testing a repurposed drug

Disease control Recruiting now

This study is testing whether the drug ruxolitinib can help adults whose immune system is attacking their bone marrow, causing severe blood diseases like aplastic anemia. Participants will take the pill twice daily for up to six months while researchers monitor their blood counts…

Matched conditions: SINGLE LINEAGE CYTOPENIAS, T-LGL

Phase: PHASE1, PHASE2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control

Last updated Mar 16, 2026 15:27 UTC

SINGLE LINEAGE CYTOPENIAS, T-LGL

Get alerted when new SINGLE LINEAGE CYTOPENIAS, T-LGL trials appear

New hope for tough blood disorders: testing a repurposed drug